FIELD: medicine.
SUBSTANCE: invention refers to medicine and aims at vaccination of anthrax. Vaccine prophylaxis is carried out by oral administration of an effective amount of a live dry lyophilised anthrax vaccine containing spores of the strain B. anthracis STI-1 and enclosed in solid gelatinous enteric capsules with a total spore concentration of 4.9±0.5 billion/ml and concentration of live spores 3.0±0.4 billion/ml.
EFFECT: method provides the formation of strained immunity and does not require special equipment and attracting qualified medical personnel.
1 cl, 6 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MIXED ANTHRAX VACCINE | 1992 |
|
RU2115433C1 |
| VACCINE AGAINST ANTHRAX AND EMPHYSEMATOUS CARBUNCLE ALIVE ASSOCIATED AND METHOD FOR PROPHYLAXIS AGAINST THESE DISEASES | 1994 |
|
RU2112544C1 |
| DNA-STRUCTURE ENCODING MODIFIED VERSION OF PROTECTIVE ANTIGENE BACILLUS ANTHRACIS | 2015 |
|
RU2622085C2 |
| ATTENUATED STRAIN Bacillus anthracis FOR DEVELOPING MEANS OF SPECIFIC PREVENTION OF ANTHRAX | 2013 |
|
RU2544951C1 |
| TEST-INFECTING CULTURE IN ASSAY OF IMMUNOGENICITY OF ANTHRAX VACCINES, EFFECTIVENESS OF AGENTS FOR EMERGENCY PROPHYLAXIS AND TREATMENT OF PATIENTS WITH ANTHRAX | 1997 |
|
RU2141522C1 |
| LIVE ANTHRAX VACCINE FOR GOATS | 2022 |
|
RU2802204C2 |
| METHOD FOR DETERMINING IMMUNOGENIC ACTIVITY OF VACCINE AGAINST ANTHRAX IN CATTLE | 0 |
|
SU1789218A1 |
| AGENT OF BACTERICIDE ACTION IN RELATES TO VEGETATIVE AND SPORE CELLS Bacillus anthracis, METHOD FOR MALIGNANT ANTHRAX PROPHYLAXIS AND TREATMENT | 2005 |
|
RU2296576C2 |
| PHARMACEUTICAL COMPOSITION FOR ANTHRAX PREVENTION AND MYIASIS AND HELMINTHIASES TREATMENT IN RUMINANTS | 2007 |
|
RU2375051C2 |
| METHOD FOR COMPLEX PROPHYLAXIS OF ANTHRAX | 2002 |
|
RU2216349C1 |
